Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Olivia Newton-John Cancer Research Institute
Jonsson Comprehensive Cancer Center
Imperial College London
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
University Health Network, Toronto
University of Alberta
University of Iowa
Crinetics Pharmaceuticals Inc.
Amgen
Merck Sharp & Dohme LLC
ITM Solucin GmbH
Sinotau Pharmaceutical Group
University of California, San Francisco
University of Iowa
Orano Med LLC
ITM Solucin GmbH
Instituto do Cancer do Estado de São Paulo
Abramson Cancer Center at Penn Medicine
Memorial Sloan Kettering Cancer Center
Harbour BioMed (Guangzhou) Co. Ltd.
Melanoma and Skin Cancer Trials Limited
University Health Network, Toronto
Providence Health & Services
University Hospital, Basel, Switzerland
Peking University
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
CHU de Quebec-Universite Laval
University Medical Center Goettingen
University of Iowa